Diabetes, but not pre-diabetes, is associated with shorter time to second-line therapy and worse outcomes in patients with multiple myeloma.
| Autor: | Avivi, Irit1,2 (AUTHOR), Yekutiel, Naama3 (AUTHOR), Cohen, Inbar1,2 (AUTHOR), Cohen, Yael C.1,2 (AUTHOR), Chodick, Gabriel2,3 (AUTHOR), Weil, Clara3 (AUTHOR) |
|---|---|
| Zdroj: | Leukemia & Lymphoma. Nov 2021, Vol. 62 Issue 11, p2785-2792. 8p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|